Your Health, We Care
Release date: 2026-01-09 16:37:48 Recommended: 51
Capmatinib is an antineoplastic agent (cancer medication). It works by interfering with the growth of cancer cells, ultimately leading to their destruction.
Capmatinib produced by Lucius Pharmaceuticals is available in a specification of 200mg*60 tablets per box, meaning each tablet has a dosage of 200mg and each box contains 60 tablets in total.
This drug is a selective MET inhibitor, indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring METex14 skipping mutation. Its price may fluctuate due to various factors, including changes in international exchange rates, costs of cold chain transportation and logistics of the drug, raw material and production process costs, regional tax policies, as well as market supply and demand.
For information on the current specific price, procurement channels or medical insurance reimbursement, please contact our customer service via the QR code on the website. We will provide you with accurate and up-to-date purchasing guidance and drug information consultation services.
Although relatively rare, capmatinib may cause some severe side effects, which require high vigilance from patients and prompt intervention when they occur.
One of the most serious side effects is the potential for severe allergic reactions, which may present as difficulty breathing or wheezing, rapid heartbeat, fever or general malaise, swollen lymph nodes, and swelling of the face, lips, mouth, tongue or throat. In addition, symptoms such as difficulty swallowing or tightness in the throat, skin itching, rash or hives, nausea and vomiting, dizziness or fainting, stomach cramps, and joint pain may also occur.
If any signs of the above allergic reactions appear, stop taking capmatinib immediately and seek emergency medical attention.
On the other hand, capmatinib may also cause lung inflammation known as interstitial lung disease or pneumonitis, which can be severe and even life-threatening. If a patient experiences difficulty breathing, seek medical attention immediately. Any new or worsening cough, fever, or shortness of breath should also be promptly reported to a doctor for evaluation and management.
Please inform your doctor of all your health conditions and any prescription or over-the-counter drugs, vitamins/minerals, herbal products, and other supplements you are taking. This will help them determine whether capmatinib is suitable for you.
Specifically, be sure to discuss the following conditions:
1. Current and past health conditions. Tell your doctor if you have or have ever had any of the following diseases.
2. Lung or breathing problems other than lung cancer.
3. Liver problems.
4. Pancreatic problems.
5. Other medications and supplements. Capmatinib may interact with other drugs and supplements. Before taking capmatinib, inform your doctor of any prescription or over-the-counter drugs, vitamins/minerals, herbal products, and other supplements you are using.
6. Pregnancy. Capmatinib may cause harm to the fetus. Before starting treatment with this drug, your doctor may perform tests to ensure you are not pregnant. If you are pregnant, think you may be pregnant, or plan to become pregnant, inform your doctor immediately. If you are of childbearing potential, you should use effective contraception during treatment with capmatinib and for one week after the last dose. Consult your doctor for contraceptive options.
7. Breastfeeding. It is unknown whether capmatinib passes into breast milk. Do not breastfeed during treatment with capmatinib and for one week after the last dose. If you are breastfeeding or plan to breastfeed, inform your doctor.
